ACTA1 and breast cancer: As mentioned earlier, our immunofluorescence results showed that the expression of EMT-related mesenchymal markers, α-SMA and N-cadherin, was decreased in the breast cancer cells treated with PKA, indicating the suppression of the EMT process at the molecular level (Figure 4).